Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

New findings do not support the recommendation for universal screening on hospital admission for methicillin-resistant Staphylococcus aureus (MRSA) to reduce the rate of hospital-acquired infections ...

While screening for methicillin resistant Staphylococcus aureus may be the method of choice for some hospitals, the efficacy of the practice remains in question, according to a study in the American ...

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...

September 13, 2009 (San Francisco, California) — Universal screening using rapid polymerase chain reaction (PCR) analysis for methicillin-resistant Staphylococcus aureas (MRSA) in hospitals appears to ...

The Veterans Health Administration (VHA) introduced its Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention Initiative in March 2007. [1] Since then, an interrupted time-series analysis [2] ...

Alexandria, VA – Pre-operative screening of patients for methicillin-resistant staphylococcus aureus (MRSA) may be an effective way to reduce infection rates following otolaryngic surgeries, according ...

There has been a sharp rise in cases of the superbug MRSA being contracted outside hospitals across the UK. Britons have been urged to avoid sharing items such as towels or razors, particularly in ...